Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Amniotic Barrier Membranes Equipment Supplied In Europe
4 equipment items found
Manufactured by:Wright Medical Group N.V. based inMemphis, TENNESSEE (USA)
Chorion based membrane (ACTISHIELD), Amnion only (see ACTISHIELD CF). Ideal handling, both dry and wet*, Adheres well without sutures*, Easy to apply topically and internally*, Creates no additional bulk at the site*, 5 year shelf life at ambient temperature. Data on File with Human Regenerative ...
Manufactured by:Wright Medical Group N.V. based inMemphis, TENNESSEE (USA)
Amnion only (ACTISHIELD™ CF), Chorion based membrane (see ACTISHIELD™). Ideal handling, both dry and wet*, Adheres well without sutures, Easy to apply topically and internally*, Creates no additional bulk at the site*, 5 year shelf life at ambient temperature. *Data on File with Human Regenerative ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
The Electrospinning Company is developing the Symatix® membrane which is an innovative synthetic amniotic membrane substitute. The membrane is created using electrospinning technology and is designed to overcome the limitation of the Human Amniotic Membrane ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
Cornea Regeneration on a synthetic membrane with limbal tissue explants. The University of Sheffield, in collaboration with the L.V.Prasad eye clinic in Hyderabad, developed corneal repair materials and procedures that offer a step change in availability and affordability. Phase I clinical trials have demonstrated patient safety. ...